Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.
| Image |  |
|---|---|
| Description | scientific article published on 28 December 2016 |
| Author/s |
author: Shinya Sato Ryuichi Noguchi |
| Publication date | February 13, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |